TURBOVAS ASP (Rosuvastatin (10mg) + Aspirin (75mg))
-15%

TURBOVAS ASP (Rosuvastatin (10mg) + Aspirin (75mg))

Original price was: ₹105.00.Current price is: ₹89.60.

TURBOVAS ASP (Rosuvastatin (10mg) + Aspirin (75mg))

Original price was: ₹105.00.Current price is: ₹89.60.

Add to cart
Buy Now
Category: Tag:

Turbovas ASP Capsule is a formulation that combines two medications aimed at reducing the risk of heart attack, stroke, and angina. This treatment works by lowering levels of “bad” cholesterol, specifically low-density lipoprotein (LDL), and triglycerides, which are types of fats in the bloodstream. Additionally, it plays a role in minimizing the chance of blood clot formation. To enhance its efficacy and reduce stomach discomfort, it is advisable to take Turbovas ASP with food. Consistent usage at specific intervals as directed by a healthcare professional is crucial, and maintaining a routine by taking it at the same time daily can benefit adherence. The prescribed dosage and duration of treatment will vary based on individual medical issues. It is critical not to discontinue use prematurely, even if symptoms improve. Alongside medication, adopting lifestyle modifications such as a low-fat diet, regular physical activity, and smoking cessation can bolster the effectiveness of Turbovas ASP. Users should remain alert for symptoms such as nausea, abdominal pain, headache, and constipation, as these may occur as side effects. Increased bleeding risk is associated with this medication, necessitating caution when handling sharp objects or participating in contact sports. Any unusual signs, including yellowing of the skin, dark urine, or muscle pain, should be reported to a healthcare provider. Prior to starting treatment, it is essential to inform the doctor of any existing liver or kidney conditions, bleeding disorders, and any other medications currently being taken.

Reviews

There are no reviews yet.

Be the first to review “TURBOVAS ASP (Rosuvastatin (10mg) + Aspirin (75mg))”

Your email address will not be published. Required fields are marked *

Top